S100A13 and differentiated thyroid carcinoma: With multiplexed and targeted mass spectrometry method, S100A13 was also found to be elevated in papillary thyroid carcinoma (PTC) compared to normal tissue, suggesting that S100A13 may be considered as a novel candidate PTC biomarker [13].